This study compared characteristics related to sexual history, sexual activities, sexual functioning, and psychological tendencies associated with sexuality in 45 young adults with schizophrenia treated with novel neuroleptics and in 61 young adults from a comparison group. A smaller proportion of young adults with schizophrenia currently had a sexual partner or had ever engaged in sexual relations. They also had sexual relations and sexual desires less often. Whether affected by schizophrenia or not, a smaller proportion of women had ever masturbated, and a smaller proportion of men currently had a sexual partner. Women masturbated less often, felt less sexual desire, and desired sexual relations less often, compared with men. Proportionally more men with schizophrenia treated with risperidone or olanzapine than men in the comparison group had at least one sexual dysfunction, lacked sexual desire, and reported problems with sexual arousal and ejaculation. Women with schizophrenia were more likely to report problems with sexual arousal and galactorrhea, compared with women in the comparison group. Finally, young adults with schizophrenia were more likely to develop negative psychological tendencies associated with sexuality than were young adults in the comparison group. Sexual problems are highly prevalent among young adults with schizophrenia. Sexuality should occupy the space it deserves within psychosocial rehabilitation programs and the treatment of schizophrenia.
The sexual life of people with schizophrenia is a dimension often overlooked if not downright ignored by mental health care professionals and researchers. Few well-controlled studies have evaluated the influence of schizophrenia on sexuality. For ethical reasons, it is practically impossible to gather a sufficiently large sample of people with schizophrenia not treated with neuroleptics. Consequently, it is difficult to dissociate the effects of the illness and those of medication on sexuality. Aizenberg et al. (1995) are the only ones who ever managed to constitute such a group in a comparative study. However, they failed to match their samples for several major sociodemographic characteristics such as educational level, income, and main occupation.
Most studies have shown that people with schizophrenia experience a progressive deterioration of their social and sociosexual functioning (Lyketsos et al. 1983; Keefe et al. 1989; Test et al. 1990; Teusch et al. 1995) . A strong proportion of women with schizophrenia lived with a spouse before separating postonset. Thereafter, while they may have sexual partners and engage in sexual relations, few of them are satisfied conjugally or sexually (Raboch 1984; McGlashan and Bardenstein 1990) . As the disorder has an earlier onset in men-that is, it appears at about the transition from adolescence to adulthood-it is more likely to thwart their acquisition of sociosexual skills (Keefe et al. 1989) . Consequently, it is more difficult for them to find a sexual partner (Verhulst and Schneidman 1991) .
People with schizophrenia have fewer sexual relations than do people without schizophrenia (Lyketsos et al. 1983; Lukoff et al. 1986; Test et al. 1990; Aizenberg et al. 1995; Bhui et al. 1995) . Autoeroticism is the principal sexual activity of men with schizophrenia (Friedman and Harrison 1984; Aizenberg et al. 1995; Lukoff et al. 1996) . Also, men with schizophrenia are more likely than their female counterparts to masturbate.
The incidence of sexual dysfunctions induced by typical neuroleptics (TN) is high, ranging from 15.0 percent to 88.9 percent, depending on the study (Mitchell and Popkin 1983; Teusch et al. 1995) . Men with schizophrenia treated with TN often present with erectile, ejaculatory, and orgasmic dysfunctions; a drop in sexual desire; and, more rarely, retrograde ejaculation and priapism (Kotin et al. 1976; Ghadirian et al. 1982; Lyketsos et al. 1983; Lukoff et al. 1986; Bhui et al. 1995) . For their part, women treated with TN often report a lack of vaginal lubrication, orgasmic dysfunctions, a drop in sexual desire, amenorrhea, and galactorrhea (Ghadirian et al. 1982; Lyketsos et al. 1983; Friedman and Harrison 1984; Teusch et al. 1995 ).
TN raise the plasma level of prolactin, thereby reducing the production of testosterone, which in turn lowers the libido and sexual desire (Wein and Van Arsdalen 1988; Waldinger 1996) . Ghadirian et al. (1982) demonstrated that TN-induced hyperprolactinemia may be associated with other sexual dysfunctions in men. It also diminishes sexual desire in women (Riley 1984; Tran et al. 1997) . A study by Tran et al. (1997) showed that a high level of prolactin increases the likelihood of orgasmic dysfunction in women. The increase in prolactin levels is also related to a higher incidence of amenorrhea, galactorrhea, engorged breasts, and menorrhagia (Ghadirian et al. 1982; Tran et al. 1997) .
Neuroleptics also act on the peripheral autonomic nervous system, which is involved in sexual functioning. They block cholinergic and alpha-adrenergic receptors, which may induce erectile, ejaculatory, and orgasmic dysfunction and, more rarely, priapism in men, as well as sexual arousal and orgasmic dysfunctions in women (Ghadirian et al. 1982; Waldinger 1996) . Lack of sexual desire is the sexual problem most often reported in studies. For example, based on a literature review, Mitchell and Popkin (1983) concluded that TN diminish sexual desire. The studies completed by Keefe et al. (1989) and Lyketsos et al. (1983) showed the decline in sexual desire to be associated with severity of schizophrenia symptoms.
Similarly, Andreasen (1982) reported the existence of negative correlations between level of sexual desire and, respectively, severity of anhedonia and of asociability associated with the illness. More recently, Aizenberg et al. (1995) demonstrated that men with schizophrenia not treated with neuroleptics had less sexual desire than did those on TN and even less so than did a comparison group of men without schizophrenia. The authors concluded that the symptoms of schizophrenia are related to lack of sexual desire and that use of TN improved the situation.
Research has shown that novel neuroleptics (NN) such as clozapine, olanzapine, and risperidone are more effective than TN in reducing the positive and negative symptoms of schizophrenia and that they induce fewer sexual dysfunctions (Chouinard et al. 1993; Crawford et al. 1996; Kane et al. 1981; Kleinberg et al. 1997; Tollefson et al. 1997; Tran et al. 1997) . Among the NN, only risperidone in high doses is likely to cause sexual dysfunctions on account of the higher rate of prolactin that is associated with it or of its adrenergic effect (Marder and Meibach 1994; Tran et al. 1997) . Marder (1996) reported that olanzapine and risperidone had little impact on sexual desire. Moreover, these studies compared two groups of patients-one treated with TN and the other with NN-but did not have a comparison group made up of persons who had no mental disorders and were not treated with neuroleptics. In addition, none of the studies of NN's effects on schizophrenia symptoms and side effects set out to examine in depth NN's effects on sexuality. Finally, no study systematically explored the relationship between cognitive functions and sexuality in young adults with schizophrenia.
This study sought to compare the sexual history, sexual activities, sexual functioning, and psychological tendencies associated with sexuality in two groups: (1) young adults with schizophrenia treated with NN in a psychiatric outpatient clinic, and (2) a comparison group of young adults without any psychopathology. A second purpose was to determine whether a relationship existed between severity of positive and negative symptoms of schizophrenia and frequency of sexual desire.
Methodology
Participants. The sample comprised 106 young adults divided into two groups. The first consisted of 45 persons with schizophrenia (20 women and 25 men). The second was made up of 61 university undergraduate students (34 women and 27 men) in die human and health sciences or administration and with no psychiatric antecedents.
Participants in the schizophrenia group received psychiatric services at the outpatient clinic for young adults with schizophrenia of Hdpital du SacnS-Coeur de Montreal. They met the following selection criteria: (1) had received a diagnosis of schizophrenia, schizophreniform disorder, or schizoaffective disorder according to DSM-IV criteria (APA 1994); (2) were aged 18 to 35 years; (3) had been treated at the psychiatric outpatient clinic for at least the past 3 months and were living in the community; (4) had been treated with the same NN for at least the past 3 months and at the same dosage for the past 2 months, with or without procyclidine; (5) had not consumed illegal drugs for at least the past 2 weeks and were not alcohol dependent; and (6) had no physical pathology affecting sexuality.
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Schizophrenia Bulletin, Vol. 29, No. 3, 2003 All of the clinic's outpatients who met the above inclusion criteria were asked to take part in the study, and 69.2 percent (45 out of 65) agreed. Of these, 34 (75.6%) had received a diagnosis of schizophrenia (14/20 or 70.0% of the women and 20/25 or 80.0% of the men), 7 (15.6%) suffered from schizoaffective disorder (5/20 or 25.0% of the women and 2/25 or 8.0% of the men), and 4 (8.9%) presented with schizophreniform disorder (1/20 or 5.0% of the women and 3/25 or 12.0% of the men).
The mean number of lifetime hospitalizations for an acute psychotic episode was 2.25 (standard deviation [SD] = 1.45) for the women and 2.28 (SD = 2.26) for the men. There was no significant difference between men and women in terms of mean number of relapses requiring hospitalization, r(43) = 0.05, p = 0.959. Mean age at time of onset of first psychotic symptoms on record was 21.8 years (SD = 3.1) for the women and 20.1 years (SD = 2.85) for the men.
Participants in the comparison group met the following inclusion criteria: (1) not treated by a psychiatrist or by hospital psychiatric services for a psychopathology in the past year, (2) aged 18 to 35 years, inclusive; (3) no consumption of psychotropic drugs; (4) no consumption of illegal drugs for at least the past 2 weeks and not alcohol dependent; and (5) no physical pathology affecting sexuality.
Demographic characteristics of participants.
Factorial univariate analyses of variance yielded no group X gender interaction effect for mean age, F(l,102) = 0.13, p = ns; mean annual income, F( 1,102) = 1.62, p -ns; or mean educational level, F(l,102) = 0.08,p -ns. Table 1 gives the frequency, mean, and SD for the demographic characteristics by group and group effects. Compared with the comparison group, the schizophrenia group was less educated (bachelor's degree not completed vs. senior high not completed) and less likely to live with a partner (n = 17 or 27.9% vs. n = 4 or 8.9%), to have at least one child (n = 9 or 14.8% vs. n = 1 or 2.2%), and to have a main occupation (n = 60 or 98.4% vs. n = 26 or 57.8%). No significant intergToup difference emerged Pearson's chi-square (oY= 1). 2 Income categories: 1 = under $5,000, 2 = $5,000-$9,999. 3 Educational level: 4.80 = partial high school education, 7.00 = bachelor's degree not completed. 4 Living with partner: 1 man and 3 women in the schizophrenia group and 9 men and 8 women in the comparison group. 5 One woman in the schizophrenia group and 1 man and 8 women in the comparison group had at least one child. 6 Percentages do not total to exactly 100 owing to rounding. 7 Three women Hved in a group home. *p<0.05; "p<0.01; "*p<0.001 regarding age, mean income, gender distribution, and proportion of participants living in their own homes.
The only significant intergender difference in terms of demographic variables was for proportion of participants with at least one child (x 2 (1) = 6.74, p = 0.01). In this regard, more women than men had at least one child (n = 9 or 16.7% vs. n = 1 or 1.9%).
Course and Procedure of Evaluation
Schizophrenia group. All the young adults with schizophrenia who met the study's selection criteria were solicited by the principal investigator to take part on a voluntary basis. Each participant was evaluated by his or her treating psychiatrist at the clinic. Each psychiatrist informed patients of the study's objectives and explained the ethical rules. An information form was signed by both the participant and the psychiatrist, who then proceeded with the evaluation, which lasted about 75 minutes. For each participant, the psychiatrist completed questionnaires on demographics and health and assessed the positive and negative symptoms of schizophrenia during a structured interview using the Positive and Negative Syndrome Scale developed by Kay et al. (1988) and the Scale for the Assessment of Negative Symptoms developed by Andreasen (1982) . In the third section of the evaluation, participants completed a selfreport questionnaire on sexual history, sexual activities, sexual dysfunctions, and menstrual problems (Fortier 1998 ) and the Multidimensional Sexuality Questionnaire developed by Snell et al. (1993) . The psychiatrist could help the participant upon request or when explanations were called for. Participants were referred to appropriate medical or sexological services, when necessary.
Comparison group. Participants in the comparison group were undergraduate university students asked to take part in the study on a voluntary basis in class during one of their courses. The researcher informed them of the study's objectives and relevance. Envelopes containing the questionnaires and the information and consent forms were handed out. The volunteers were instructed to complete the questionnaires at home. One covered demographics and health, and another, sexual activity, sexual dysfunctions, and menstrual problems (Fortier 1998) . Included in the package was the Multidimensional Sexuality Questionnaire by Snell et al. (1993) . The envelopes were returned to the researcher in class the following week. Of the 310 persons solicited, 99 agreed to take part in the present research, for a 32.0 percent participation rate. Thirty-eight of the questionnaires returned were rejected because they had been improperly completed or because the person did not meet the selection criteria.
Data Analysis. The data gathered in the course of the study were analyzed using SPSS, version 7.0 (1995). Intergroup and intergender comparisons on continuous variables were carried out using Student / tests. Group X gender comparisons on continuous variables were conducted using factorial univariate analyses of variance. Fisher's exact tests or chi-square tests were run on categorical variables to compare groups and genders. Correlational analyses were performed to determine whether there was a relationship between schizophrenia symptoms and sexual desire.
Results
As shown in table 2, risperidone was the most commonly used neuroleptic (n = 25 or 55.6%) at a mean dosage of 3.80 mg/day, followed by olanzapine (n = 17 or 37.8%) at a mean dosage of 16.62 mg/day, and clozapine (n = 3 or 6.7%). One man took 700 mg/day of clozapine and two women 600 and 150 mg/day, respectively. There was no significant difference between men and women in terms of mean daily dosage of risperidone and olanzapine. No significant difference emerged between persons treated with olanzapine and those treated with risperidone regarding severity of overall negative and positive symptoms of schizophrenia. Six patients (four women and two men) consumed an antidepressant in addition to a neuroleptic. Among the women, one took paroxetine (20 mg/day), one fluoxetine (40 mg/day), and two others clomipramine (75 and 100 mg/day). Among the men, one consumed fluvoxamine (80 mg/day) and the other sertraline (200 mg/day).
Severity of Positive and Negative Symptoms by
Gender. Table 3 shows that participants in the schizophrenia group on average presented with low severity of positive and negative symptoms. Compared with women, men had hallucinations, t(43) = 2.31, p = 0.026; delusions of grandeur, /(43) = 2.28, p = 0.030; and a more severe overall positive symptomatology, t{43) = 2.05, p = 0.048. No significant intergender difference was observed in terms of mean severity of negative symptoms. Overall, however, men were slightly more symptomatic than women.
Descriptive Analysis of Sexual History. When the four groups that made up the sample were compared, it was found that only 12.0 percent of men with schizophrenia currently had a sexual partner, compared with 35.0 percent of their female counterparts, 70.3 percent of men in the comparison group, and 79.4 percent of women in the comparison group (table 4) . However, a slightly higher proportion of men with schizophrenia than of women with schizophrenia (68.0% vs. 60.0%) had had a sexual relationship.
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Student ftest (df<= 43).
2 Severity scale for positive symptoms of schizophrenia (Kay et al. 1988 ): 1 = absent, 2 = slight, 3 = mild, 4 = moderate, 5 = moderatesevere, 6 = severe, and 7 = extreme. 3 Scale to assess negative symptoms of schizophrenia (Andreasen 1982) . Level of psychiatrist's global assessment: 0 = absent, 1 = doubtful, 2 = slight, 3 = moderate, 4 = marked, 5 = severe. *p<0.05; " p < 0.01; *** p<0.001
Only one man and three women from the comparison group had never had a sexual relationship. An almost equal proportion of men and women with schizophrenia (36.0% vs. 40.0%) had had sexual relations at least once in the past year, compared with the majority of men and women in the comparison group (88.9% vs. 88.2%).
In the schizophrenia group, all the men but only half the women had ever masturbated. Proportionally more women in the comparison group than women with schizophrenia had ever masturbated (76.5% vs. 50.0%). Slighty fewer men in the comparison group (88.9%) than men with schizophrenia had ever engaged in this activity.
All the men with schizophrenia reported some sexual activity at least once in the past 3 months (masturbation or sexual relations). A relatively smaller proportion of women in the schizophrenia group had had some sexual activity over the same period, compared with those in the comparison group (60.0% vs. 94.1%). Only one man and two women in the comparison group had had no sexual activity in the past 3 months.
The distribution of the frequency with which characteristics related to sexual history were present in each group revealed significant intergroup differences regarding the proportion of participants who currently had a sex- ual partner, ^(1) = 29.40, p*0; who had ever had sexual relations, X 2 (l) = 14.22, p -° 0; and who had had some sexual activity in the past 3 months, x 2 0) = 4.60, p = 0.032. Relative to the comparison group, a smaller proportion of persons with schizophrenia currently had a sexual partner (22.2% vs. 75.4%), had ever had sexual relations (64.4% vs. 93.4%), or had had some sexual activity in the past 3 months (82.2% vs. 95.1%). There were no significant intergroup differences in terms of the percentage of participants who had ever masturbated.
When all the groups were combined, significant intergender differences emerged regarding the proportion of participants who currently had a sexual partner, X 2 (l) = 4.53, p = 0.033; who had ever masturbated, x 2 (l) = 12.67, p «• 0; or who had had some sexual activity in the past 3 months, X 2 (l) = 4.60, p = 0.005. More men than women had ever masturbated (94.2% vs. 66.7%), had had some sexual activity in the past 3 months (98.1% vs. 81.5%), or currently had no sexual partner (57.7% vs. 37.0%). There was no significant difference in the relative proportion of men and women who had ever had a sexual relationship.
Sexual Activities. Analysis of variance (ANOVA) results revealed no group X gender interaction effect for the measures of sexual activity used. Table 5 gives frequency of sexual activity by group. Participants in the schizophrenia group on average reported fewer sexual relations (mean = 8.22 [slightly less than once a month] vs. mean = 5.23 [nearly once a week]) and less sexual desire (mean = 3.69 [slightly more than twice a week] vs. mean = 3.10 [nearly three or four times a week]) than did those in the comparison group. Participants in the two groups were comparable in terms of mean desired frequency of sexual relations (slightly more than twice a week) and masturbation (about once every 2 weeks) and of mean number of lifetime sexual partners (three or four sexual partners per participant). When the six persons with schizophrenia who took antidepressants in addition to neuroleptics were excluded from the sample, the same significant intergroup differences emerged regarding sexual relations and sexual desire. Mean frequencies remained lower for the schizophrenia group.
When all groups were combined, significant intergender differences were noted regarding frequency of the fol- 
Relationship Between Residual Positive and Negative
Symptoms and Sexual Desire. Correlational analyses showed that there was no relationship between frequency of sexual desire and global severity of positive (r = 0.06, p = 0.69) and negative (r = -0.21, p = 0.163) symptoms, respectively. However, all the correlational analyses carried out between frequency of sexual desire and severity of each positive or negative symptom of schizophrenia indicated the existence of a negative correlation between severity of affective flattening and frequency of sexual desire (r = -0.38, p = 0.011). In other words, as affective flattening increases in severity, frequency of sexual desire declines. However, the strength of the link between these 2 Frequency level of sexual activity: 1 = more than once a day, 2 = once a day, 3 = three or four times a week, 4 = twice a week, 5 = once a week, 6 = once every 2 weeks, 7 = once a month, 8 = less than once a month, 9 = not at all. 3 Lifetime number of sexual partners: 1 = more than ten, 2 = eight to ten, 3 = six or seven, 4 = five, 5 = four, 6 = three, 7 = two, 8 = one, 9 = none.
* p < 0.05; " p < 0.01; *** p < 0.001 two variables proved rather weak, as only 14.4 percent of the variance in frequency of sexual desire was accounted for by the variance in severity of affective flattening. No other relationship was observed between frequency of sexual desire and severity of positive symptoms or of other negative symptoms of schizophrenia. This can be explained in large part by the small variability in the severity of symptoms in our sample.
Male Sexual Dysfunctions by Group. As shown in table 6, a much higher proportion of men with schizophrenia than of men in the comparison group reported sexual disturbances. In this regard, 60.9 percent of the men with schizophrenia treated with NN and 15.4 percent of the men in the comparison group presented with at least one sexual dysfunction. This difference was statistically significant, x 2 (l) = 10.86, p ~ 0. A number of significant differences were noted between the men of the two groups. Participants who took antidepressants (four women and two men) were excluded from this analysis on account of the sexual dysfunctions that these drugs can induce (Wasyluk 1992) . Participants who had no sexual activity in the past 3 months were also excluded (except from analyses regarding lack of sexual desire).
Compared with men in the comparison group, a higher percentage of men with schizophrenia presented with a lack of sexual desire, sexual arousal dysfunction, delayed ejaculation, and anejaculation.
Also, even though a greater proportion of men in the schizophrenia group reported orgasmic and erectile disturbances than did those in the comparison group, the differences did not prove statistically significant. Table 7 presents the distribution of the frequency with which sexual dysfunctions were present in the women of both groups who were sexually active in the past 3 months. Although a higher proportion of women with schizophrenia not treated with antidepressants (60.0%) than of women in the comparison group (40.6%) presented with at least one sexual dysfunction, the intergroup difference did not prove significant.
Female Sexual Dysfunctions by Group.
Orgasmic problems were the sexual dysfunction most commonly reported by the women in both groups. Compared with the women in the comparison group, a higher proportion of women with schizophrenia treated with neuroleptics presented with a sexual arousal dysfunction. No other significant intergroup difference was noted regarding the other dimensions of sexual functioning. 
Menstrual and Hormonal Disturbances in Women.
Results from Fisher's exact tests revealed a significant intergroup difference in terms of the proportion of women with galactorrhea (p = 0.002). No woman from the comparison group reported galactorrhea, compared with five from the schizophrenia group who used only neuroleptics (n = 16; 31.3%). No significant difference emerged between the women of the two groups regarding frequency of menstrual disturbances. However, two cases of total absence of menstruation (12.5%) were reported in the schizophrenia group (n = 16).
Sexual Dysfunctions of Participants With Schizophrenia and Hormonal Disorders by Group and Type of
Neuroleptic. The small size of the sample precluded the use of inferential statistical analyses to verify which drug was most strongly associated with the presence of a sexual dysfunction for each group of men and women treated with risperidone and olanzapine. A descriptive analysis showed that at least one out of two persons with schizophrenia (50.0% to 66.7%) had a sexual dysfunction of some type regardless of the neuroleptic taken. Compared with olanzapine users, a higher proportion of risperidone users presented with a sexual disturbance in each sexual dysfunction category, with the exception of sexual arousal and erectile disorders in men and genital pain in women. Risperidone tended to be associated with a higher presence of anejaculation (n = 4/14 or 28.6% vs. n = 1/8 or 12.5%) and delayed ejaculation in men (n = 3/14 or 21.4% vs. n = 1/8 or 12.5%), with orgas-Neuroleptic Treatment and Sexuality-Related Characteristics Schizophrenia Bulletin, Vol. 29, No. 3, 2003 mic disorders in women (« = 4/6 or 66.7% vs. n = 1/4 or 25.0%), and with lack of sexual desire in both men and women (n -3/14 or 21.4% to n = 3/9 or 33.3% vs. n = 0/6 or 0% to n = 1/8 or 12.5%), with vaginal dryness (n = 2/6 or 33.3% to n =1/4 or 25.0%) and sexual arousal dysfunction (n = 3/6 or 50.0% to n = 1/4 or 25.0%) in women.
Furthermore, for those free of antidepressant, four out of six women treated with olanzapine reported galactorrhea, which is far from being negligible, compared with one out of nine treated with risperidone. These differences, however, did not prove statistically significant. Among the women treated with risperidone or olanzapine, only one on olanzapine had been exposed to another neuroleptic, namely, risperidone 3.5 mg. She presented with galactorrhea. The switch to olanzapine occurred 5 months before the start of data collection. Consequently, we cannot entirely rule out the possibility that this symptom flourished under risperidone and continued under olanzapine. A verification of prolactin levels might have shed some light on the history of the symptom. Unfortunately, this was not done.
It came as a surprise that, even at low or moderate doses, both types of NN seemed to be associated with the presence of sexual dysfunctions, amenorrhea, and galactorrhea. At least one sexual dysfunction was present in 8 out of 17 (47.1%) participants treated with risperidone (1-4 mg), compared with 4 out of 6 persons (66.6%) treated with olanzapine (5-17 mg). Amenorrhea or galactorrhea was present in two out of six women treated with risperidone (33.3%), compared with one out of two women treated with olanzapine (50.0%).
Psychological Tendencies Associated With Sexuality.
ANOVA results indicated no group X gender interaction effect for any of the psychological tendencies associated with sexuality that were evaluated. Table 8 gives the group effects for 8 out of the 12 psychological tendency measures. The schizophrenia group posted weaker results with respect to a number of psychological tendencies associated with sexuality. These participants had weaker sexual esteem, weaker sexual consciousness, less internal sexual control, and a stronger impression that external factors determined the aspects of their sexual life. Moreover, the young adults with schizophrenia were more preoccupied about their sexuality, were more afraid of engaging in sexual relations, and felt more depressed about and dissatisfied with their sexual life.
With all groups combined, women and men were comparable with respect to most of the psychological tendencies associated with sexuality. However, men were characterized by stronger sexual preoccupation, F( 1,102) = 17.9, p «*• 0; greater sexual monitoring (the tendency to be aware of the public impression that one's sexuality makes on others), F(l,102) = 5.03, p = 0.027; and greater sexual esteem compared with women, F(l,102) = 6.35,p = 0.013. 
Discussion
As demonstrated in the studies by Chouinard et al. (1993) , Crawford et al. (1996), Maider and Meibach (1994) , Tollefson et al. (1997) , and Tran et al. (1997) , NN seem to control the symptoms of schizophrenia relatively well. However, sexual problems are highly prevalent among young adults with schizophrenia. Compared with their nonschizophrenia counterparts, young adults with schizophrenia present with less sexual activity, more sexual dysfunctions, and more negative psychological tendencies associated with sexuality.
Sexual History. Participants from the two groups in this study did not differ in terms of mean number of lifetime sexual partners. The schizophrenia group had on average three or four sexual partners. These results are similar to those reported in the U.S. study of sexuality conducted by Laumann et al. (1994) but diverge from the conclusions reached in the study by Teusch et al. (1995) to the effect that young adults with schizophrenia tend to have fewer sexual partners than do persons without schizophrenia and that men with schizophrenia have fewer than do women with schizophrenia. However, as was also reported by Test et al. (1990) , a significantly smaller proportion of young adults with schizophrenia currently had a sexual partner (22.2% vs. 75.4%). These individuals seem to have difficulty hanging on to sexual partners, and a strong proportion of them have never engaged in sexual relations. As expected, the proportion of young adults who had already masturbated was comparable in the two groups. In all groups combined, proportionally more men than women had ever masturbated (94.2% vs. 66.7%). This intergender difference is even more pronounced within the schizophrenia group. As reported by Friedman and Harrison (1984) , one out of two women with schizophrenia had never masturbated and, as reported by Keefe et al. (1989) , all men with schizophrenia had already masturbated.
Sexual Activities. Regardless of gender, young adults with schizophrenia had sexual relations and sexual desires less often than did the young adults in our comparison group. As was the case in the studies by Lyketsos et al. (1983) and Teusch et al. (1995) , the schizophrenia participants in this study on average engaged in sexual relations slightly less than once a month. This contrasts with the results obtained by Aizenberg et al. (1995) , who noted a higher frequency of sexual relations-that is, slightly less than once a week. However, the group effect on frequency of sexual desire is congruent with the conclusions reached by Aizenberg et al. (1995) . In other words, like young adults without schizophrenia, those with schizophrenia on average would like to have more sexual relations, namely slightly more than twice per week.
Regardless of gender, the comparison and schizophrenia groups did not differ with respect to frequency of masturbation. Aizenberg et al. (1995) found that men with schizophrenia masturbated more often than did their nonschizophrenia counterparts, but the men in the two groups of this study did not differ in terms of mean frequency of masturbation (about once every 2 weeks). Also, men masturbated and had sexual desires more often than did women. Although all the participants desired to have sexual relations more often, men desired a higher frequency of sexual relations than did women.
Contrary to the results of McGlashan and Bardenstein (1990) , who noted that women with schizophrenia had twice as many sexual relations as did their male counterparts, no significant intergender difference emerged within the schizophrenia group of the present study. Autoeroticism was the type of sexual activity most often practiced in the schizophrenia group. Generally speaking, however, young adults with schizophrenia had few sexual relations.
Relationship Between Residual Positive and Negative
Symptoms and Sexual Desire. Unlike Keefe et al. (1989) and Lyketsos et al. (1983) , we found no relationship between severity of residual positive and negative symptoms of schizophrenia (except for affective flattening) and frequency of sexual desire. However, the weak correlations that emerged between severity of symptoms and level of sexual desire were explained in part by the weak variability of symptoms in our study. The low mean frequency of sexual desire among young adults with schizophrenia treated with NN remains in large part unexplained, hi short, severity of residual symptoms has little influence on sexual desire.
Contrary to the conclusions reached by Andreasen (1982) , the results of this study demonstrate that there exists no relationship between severity of anhedonia and frequency of sexual desire.
All told, the results regarding sexual history and profile of activities are in line with the theory proposed by Bhui et al. (1995) and Keefe et al. (1989) according to which people with schizophrenia have poor sociosexual skills compared with persons without schizophrenia. This shortcoming could be a reflection of the disorder's negative symptoms, which are often present before the patient's first psychiatric consultation and which interfere with the acquisition of these skills.
Sexual Dysfunctions. Schizophrenia and NN use are associated with a high rate of sexual dysfunctions (60%). Compared with the men in our comparison group, a significantly higher proportion of men with schizophrenia presented with sexual arousal dysfunction (34.8%), anejaculation (26.1%), delayed ejaculation (21.7%), and lack of sexual desire (17.4%).
Men with schizophrenia were more likely to report orgasmic and erectile disturbances (26.1% and 21.7%, respectively) than were the men in the comparison group, although the differences did not reach statistical significance. Aside from premature ejaculation (20.0%), the men in the comparison group reported few sexual dysfunctions.
Although the proportion of men with schizophrenia treated with NN who presented with various sexual problems was higher than expected, they nevertheless proportionally seem to present with fewer sexual dysfunctions than do those treated with TN, as reported in the body of research on the subject.
Of the few studies that reported the incidence or prevalence rate of certain sexual dysfunctions among men treated with NN, all yielded frequencies below those observed in the present study. These rates ranged from 2.8 percent (Tran et al. 1997 ) to 15.0 percent (Kleinberg et al. 1997) for ejaculatory dysfunctions and from 0.7 percent (Crawford et al. 1996) to 15.0 percent (Kleinberg et al. 1997) for erectile dysfunctions. Lack of sexual desire was present in 13.2 percent of the men in the study by Crawford et al. (1996) and 1.0 percent of those in the study by Kleinberg et al. (1997) .
Compared with women in the comparison group, a significantly higher proportion of women with schizophrenia treated with NN presented with a sexual arousal dysfunction (40.0%) and galactorrhea (31.3%). Although the two groups did not differ significantly with respect to the presence of other sexual and hormonal problems, proportionally more women with schizophrenia reported a problem in each category of hormonal and sexual disturbance evaluated.
The frequencies for sexual disturbances, which varied from 20.0 percent for genital pain to 50.0 percent for orgasmic dysfunction, are comparable to the results reported in the studies by Friedman and Harrison (1984) , Ghadirian et al. (1982) , Lyketsos et al. (1983), and Teusch et al. (1995) , which focused on the side effects of TN.
Few studies have noted the presence of sexual dysfunctions, galactorrhea, or amenorrhea among women with schizophrenia treated with NN. Marder and Meibach (1994) reported a few cases of orgasmic disorder, and Kleinberg et al. (1997) showed that 1.0 percent of women treated with NN experienced a drop in their libido, along with amenorrhea and galactorrhea in 10.0 percent of them.
The results of the present study indicated no significant difference between the two groups of men and the two groups of women treated with risperidone and olanzapine with respect to frequency of sexual dysfunctions for all categories of sexual problems investigated and to hormonal problems in women. Slightly more than one out of two persons with schizophrenia presented with at least one sexual dysfunction regardless of the neuroleptic used.
However, a descriptive analysis of the results revealed that, compared with those treated with olanzapine, proportionally more men treated with risperidone reported anejaculation, delayed ejaculation, and lack of sexual desire; and more women reported sexual arousal and orgasmic dysfunctions, vaginal dryness, lack of sexual desire, and amenorrhea. Galactorrhea is more prevalent among the olanzapine group. The small size of the groups did not make it possible to verify whether, as asserted by Tran et al. (1997) , risperidone was significantly more often associated with the presence of sexual dysfunctions and hormonal problems. Crawford et al. (1996 ), Marder (1996 , Kleinberg et al. (1997) , and Tollefson et al. (1997) concluded that, in low doses, risperidone caused little sexual dysfunction, amenorrhea, or galactorrhea. The results of the present study indicate, instead, that about one out of two persons with schizophrenia treated with low to moderate doses of risperidone or olanzapine presented with at least one sexual dysfunction and that numerous women with schizophrenia had amenorrhea or galactorrhea.
It is difficult to say why a higher proportion of the participants with schizophrenia in this research presented with sexual and hormonal problems compared with those in other studies. One possible explanation is that, while the other studies measured incidence, the results of this research were an approximation of the prevalence rate of sexual dysfunctions and hormonal problems associated with the presence of schizophrenia and NN use. Consequently, it would be normal for the prevalence rates obtained for the sexual problems examined to be higher than the incidence rates reported in the other studies. Moreover, it is important to bear in mind that, given the impossibility of dissociating the effects of the illness from those of neuroleptics on sexual functioning, it is impossible to conclude that these dysfunctions are directly related to the secondary effects of NN. Also, most research protocols to date have not been designed for an in-depth evaluation of the effects of NN on sexuality.
Psychological Tendencies Associated With Sexuality.
Compared with young adults without any psychopathology, young adults with schizophrenia have more negative psychological tendencies associated with sexuality. The latter on average have lower sexual esteem, have greater fear of sex, are more preoccupied with their sexuality, and feel more depressed about and dissatisfied with their sex life.
It is likely that young adults with schizophrenia, who for the most part have little experience in terms of sexual interaction and possess poorly developed premorbid sociosexual skills (Raboch 1984; Keefe et al. 1989) , are inclined to develop a negative cognition toward their sexual life, sexual abilities, and sociosexual skills postonset. These negative psychological tendencies may inhibit behaviors that lead to satisfactory sexual and sociosexual exchanges. In this regard, young adults with schizophrenia may be more inclined than young adults without any psychopathology to avoid situations that could lead to sexual exchanges and, when exposed to these situations, risk experiencing fear, lack of confidence, and depressive feelings. These negative psychological tendencies associated with sexuality may be associated with the development and maintenance of certain sexual dysfunctions and may contribute to reduced frequency of sexual desire and of desire for sexual relations.
Compared with our comparison group, the group of young adults with schizophrenia on average had less of an impression of being responsible for their sexuality and of having control over their sexual life. Along the same lines, these persons were more likely to believe that aspects of their sexual life were determined by external factors or chance. Such beliefs would not encourage these individuals to be very proactive or enterprising in the area of sexuality.
This research also showed that young adults with schizophrenia had a harder time gaining awareness of and understanding their feelings and desires related to sexuality, compared with young adults in the comparison group. The cognitive impairments related to attention, anterograde memory, judgment, abstract thought, and self-criticism, among other things, that are often present in varying degrees of severity in these individuals (Crow 1980; Andreasen 1982; Wyatt 1986; Murray et al. 1992 ) may explain in part this intergroup difference.
Young adults with schizophrenia were less motivated to be sexually active than were those in the comparison group. This difference came close to reaching statistical significance (p = 0.066). A narrower spread was expected between the means of the two groups for this variable, particularly as the adults in both groups desired on average two or three sexual relations per week. In other words, young adults with schizophrenia would like to have sexual relations as often as young adults without any psychopathology but tend to be less motivated to make the necessary efforts and feel less sexual desire.
Whether or not they have schizophrenia, men on average have better sexual esteem, are more preoccupied with their sexuality, and are more susceptible to sexual monitoring, compared with women. Men with and without schizophrenia reported on average more self-confidence in the sexual sphere and better skills as sexual partners, compared with women. These results run contrary to the conclusions drawn by Teusch et al. (1995) and Verhulst and Schneidman (1991) to the effect that men with schizophrenia possess weaker sociosexual skills than do women on account of their poorer premorbid sexual functioning.
Limitations of the Study. One of the principal limitations of this research resides in the fact that it is impossible to dissociate the influence of schizophrenia from that of NN on sexual activities, psychological tendencies associated with sexuality, and the sexual functioning of participants. Furthermore, baseline for sexual functioning could not be measured prior to neuroleptic intake because the participants were already taking medication before the start of the research. Several other variables were not controlled for, such as placebo effect, duration of pharmacological treatment, earlier traumatic events capable of inducing sexual dysfunction, and sexual aggressions.
Also, generalization of the research results is limited by the representativeness of the schizophrenia group. In this connection, a strong proportion of the persons with schizophrenia who took part in the study were more cooperative, freer of illicit drugs, and less symptomatic, compared with those who refused to participate. In this regard, refusers were among the most perturbed and least functional of die schizophrenia patients solicited, and various aspects of their sexual life may differ from those of the participants.
The validity of the research is compromised also by the lack of representativeness of the comparison group, which was made up of only university students. In this regard, non-university students in the same age group may have different characteristics related to sexuality than those of the participants in this research. As demonstrated by Laumann et al. (1994) , educational level is related to certain aspects of sexuality. According to these researchers, the proportion of men and women who masturbate increases with years of schooling, and the more women are educated, the less they suffer from orgasmic dysfunctions or lack of sexual desire. This variable should be controlled in future studies.
Conclusion
Even when the symptoms of schizophrenia are relatively well controlled by NN, sexual problems are highly prevalent among young adults with schizophrenia. A review of the literature reveals that these problems are clearly underestimated by clinicians and researchers. All physicians who prescribe NN should inform their clients of the medication's possible effect on sexual functioning. They should also carry out a systematic evaluation of their clients' sexual functioning by administering a questionnaire before the start of intake and periodically thereafter.
Mental health and other professionals who intervene with young adults suffering from schizophrenia must better evaluate and identify the psychological problems that have a negative influence on sexual functioning and qual-Ncuroleptic Treatment and Sexuality-Related Characteristics Schizophrenia Bulletin, Vol. 29, No. 3, 2003 ity of sexual life. Sexuality should be integrated into the intervention plan and psychosocial rehabilitation program offered to schizophrenia patients. In this regard, a sex education program like the one designed by Lukoff et al. (1986) could enable these young adults to acquire basic knowledge of sexuality and requisite skills in this area of functioning. In addition, cognitive-behavioral therapies to treat certain sexual dysfunctions should be offered to persons who wish to improve sexual functioning. Finally, future research should be conducted also with a view to better understanding the influence of NN on the biological mechanisms related to sexual functioning.
